PURPOSE: To estimate lifetime risk of receiving an HIV diagnosis in the United States if existing infection rates continue. METHODS: We used mortality, census, and HIV surveillance data for 2010 to 2014 to calculate age-specific probabilities of an HIV diagnosis. The probabilities were applied to a hypothetical cohort of 10 million live births to estimate lifetime risk. RESULTS: Lifetime risk was 1 in 68 for males and 1 in 253 for females. Lifetime risk for men was 1 in 22 for blacks, 1 in 51 for Hispanic/Latinos, and 1 in 140 for whites; and for women was 1 in 54 for blacks, 1 in 256 for Hispanic/Latinas, and 1 in 941 for whites. By risk group, the highest risk was among men who have sex with men (1 in 6) and the lowest was among male heterosexuals (1 in 524). Most of the states with the highest lifetime risk were in the South. CONCLUSIONS: The estimates highlight different risks across populations and the need for continued improvements in prevention and treatment. They can also be used to communicate the risk of HIV infection and increase public awareness of HIV. Published by Elsevier Inc.
PURPOSE: To estimate lifetime risk of receiving an HIV diagnosis in the United States if existing infection rates continue. METHODS: We used mortality, census, and HIV surveillance data for 2010 to 2014 to calculate age-specific probabilities of an HIV diagnosis. The probabilities were applied to a hypothetical cohort of 10 million live births to estimate lifetime risk. RESULTS: Lifetime risk was 1 in 68 for males and 1 in 253 for females. Lifetime risk for men was 1 in 22 for blacks, 1 in 51 for Hispanic/Latinos, and 1 in 140 for whites; and for women was 1 in 54 for blacks, 1 in 256 for Hispanic/Latinas, and 1 in 941 for whites. By risk group, the highest risk was among men who have sex with men (1 in 6) and the lowest was among male heterosexuals (1 in 524). Most of the states with the highest lifetime risk were in the South. CONCLUSIONS: The estimates highlight different risks across populations and the need for continued improvements in prevention and treatment. They can also be used to communicate the risk of HIV infection and increase public awareness of HIV. Published by Elsevier Inc.
Authors: Ron Stall; Luis Duran; Stephen R Wisniewski; Mark S Friedman; Michael P Marshal; Willi McFarland; Thomas E Guadamuz; Thomas C Mills Journal: AIDS Behav Date: 2009-02-10
Authors: Derrick D Matthews; A L Herrick; Robert W S Coulter; M Reuel Friedman; Thomas C Mills; Lisa A Eaton; Patrick A Wilson; Ron D Stall Journal: AIDS Behav Date: 2016-01
Authors: David W Purcell; Christopher H Johnson; Amy Lansky; Joseph Prejean; Renee Stein; Paul Denning; Zaneta Gau; Hillard Weinstock; John Su; Nicole Crepaz Journal: Open AIDS J Date: 2012-09-07
Authors: Sara LeGrand; Kathryn E Muessig; Keith J Horvath; Anna L Rosengren; Lisa B Hightow-Weidman Journal: Curr Opin HIV AIDS Date: 2017-09 Impact factor: 4.283
Authors: David W Pantalone; Kimberly M Nelson; Abigail W Batchelder; Christopher Chiu; Hamish A Gunn; Keith J Horvath Journal: J Sex Res Date: 2020-02-20
Authors: Deven T Hamilton; Steven M Goodreau; Samuel M Jenness; Patrick S Sullivan; Li Yan Wang; Richard L Dunville; Lisa C Barrios; Eli S Rosenberg Journal: Am J Public Health Date: 2018-11 Impact factor: 9.308
Authors: Sarah K Calabrese; John F Dovidio; Mehrit Tekeste; Tamara Taggart; Rachel W Galvao; Cara B Safon; Tiara C Willie; Abigail Caldwell; Clair Kaplan; Trace S Kershaw Journal: J Acquir Immune Defic Syndr Date: 2018-09-01 Impact factor: 3.731
Authors: Sean M Murphy; Jared A Leff; Benjamin P Linas; Jake R Morgan; Kathryn McCollister; Bruce R Schackman Journal: Subst Abus Date: 2018 Impact factor: 3.716
Authors: Alyson L Singleton; Brandon D L Marshall; Xiao Zang; Amy S Nunn; William C Goedel Journal: AIDS Patient Care STDS Date: 2020-11-19 Impact factor: 5.078